Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down
- 31 March 2006
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 117 (3), 563-570
- https://doi.org/10.1016/j.jaci.2005.11.036
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Goals of asthma treatment: how high should we go?European Respiratory Journal, 2004
- Can Guideline-defined Asthma Control Be Achieved?American Journal of Respiratory and Critical Care Medicine, 2004
- Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysJournal of Allergy and Clinical Immunology, 2004
- Development of the asthma control test☆A survey for assessing asthma controlJournal of Allergy and Clinical Immunology, 2004
- Stepping down inhaled corticosteroids in asthma: randomised controlled trialBMJ, 2003
- Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthmaThorax, 2002
- Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 μg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthmaRespiratory Medicine, 2001
- Clinical Equivalence of a Salmeterol/Fluticasone Propionate Combination Product (50/500??g) Delivered via a Chlorofluorocarbon-Free Metered-Dose Inhaler with the Diskus??? in Patients with Moderate to Severe AsthmaClinical Drug Investigation, 2001
- Optimal asthma control, starting with high doses of inhaled budesonideEuropean Respiratory Journal, 2000
- Clinical Control and Histopathologic Outcome of Asthma when Using Airway Hyperresponsiveness as an Additional Guide to Long-Term TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 1999